CROSSROADS STRATEGIES, LLC for VERTEX PHARMACEUTICALS INCORPORATED
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about sickle cell disease therapy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SALIM ALAMEDDIN | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| CHERYL LYNN JAEGER | — |
| MATHEW LAPINSKI | — |
| IVELISSE ALEXANDRA PORROA-GARCIA | — |
| JASON BENJAMIN VAN PELT | — |
Medical/Disease Research/Clinical Labs MED
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about sickle cell disease therapy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SALIM ALAMEDDIN | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| CHERYL LYNN JAEGER | — |
| MATHEW LAPINSKI | — |
| IVELISSE ALEXANDRA PORROA-GARCIA | — |
| JASON BENJAMIN VAN PELT | — |
Medicare/Medicaid MMM
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs. Education about non-opioid pain therapies. S.3832/H.R.7142, Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SALIM ALAMEDDIN | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| CHERYL LYNN JAEGER | — |
| MATHEW LAPINSKI | — |
| IVELISSE ALEXANDRA PORROA-GARCIA | — |
| JASON BENJAMIN VAN PELT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.